KraneShares MSCI All China Health Care Index ETF KURE

Morningstar Medalist Rating

Morningstar’s Analysis KURE

Will KURE outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

KraneShares MSCI All China Hlth Care ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings KURE

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings54.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

BeOne Medicines Ltd Ordinary Shares

9.8911M
Healthcare

Innovent Biologics Inc

8.149M
Healthcare

WuXi Biologics (Cayman) Inc

7.498M
Healthcare

Wuxi AppTec Co Ltd Class A

5.586M
Healthcare

Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A

4.655M
Healthcare

Jiangsu Hengrui Pharmaceuticals Co Ltd Class A

4.625M
Healthcare

Sino Biopharmaceutical Ltd

4.034M
Healthcare

CSPC Pharmaceutical Group Ltd

3.424M
Healthcare

Wuxi AppTec Co Ltd

3.194M
Healthcare

Hansoh Pharmaceutical Group Co Ltd

3.153M
Healthcare

Sponsor Center